News

The President was seen wearing what looked to be concealer on his hand to hide his apparent bruising on Tuesday, in the latest incident to spark concerns over the Presidents health.
The first hemophilia B patient in Germany received gene therapy Hemgenix, covered by public healthcare with efficacy-tied reimbursement.
The petition was filed by Prema Ram who appeared in the Civil Services Examination conducted by the Union Public Service Commission (UPSC) in May this year ...
Contaminated blood scandal campaigners have challenged the Government to act in response to a new report laying out ...
The Government’s “failure” to listen to victims of the infected blood scandal has been “exposed” in a new report, campaigners have said. The Haemophilia Society said that victims of the scandal, ...
Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...
Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance induction, a study found.
Pfizer has reported positive topline outcomes from the multicentre, open-label Phase III BASIS trial of Hympavzi (marstacimab) for adults and adolescents with haemophilia A or B with inhibitors. The ...
Pfizer has shared positive top-line results from a late-stage study of its haemophilia A and B therapy Hympavzi (marstacimab). The phase 3 BASIS trial has been evaluating the drug in adult and ...
If you bruise easily, it could be more than delicate skin. Haemophilia B is a rare bleeding disorder that often goes undiagnosed. Learn about its signs, causes, and treatment with expert insights.